X
XLinkedinWhatsAppTelegramTelegram
0
Read this article in:

Development of a synthetic PRRSv strain that confers broader cross-protection

The results demonstrate that the PRRSV-CON virus can serve as a potential vaccine candidate for the development of a novel PRRS vaccine with broader cross-protection.

22 April 2015
X
XLinkedinWhatsAppTelegramTelegram
0

Substantial genetic variation among PRRSV strains represents a major obstacle for the development of a broadly protective vaccine. We describe here a novel approach to generate a PRRSV vaccine strain that could confer broad cross-protection against divergent PRRSV isolates.

We had initially obtained a set of 60 non-redundant, full-genome sequences of type-II PRRSV. After that, we generated the consensus genome (designated as PRRSV-CON) by aligning the 60 PRRSV full-genome sequences, followed by selecting the most common nucleotide found at each position of the alignment. Our analysis demonstrates that the PRRSV-CON has the highest degree of sequence identity to the PRRSV field-isolates when compared to any current PRRS vaccine strains, both at the full-genome level and the individual gene level. Next, we chemically synthesized the PRRSV-CON genome and assembled it into a bacterial plasmid under the control of the T7 promoter. The resulting PRRSV-CON cDNA clone is fully infectious. Viable virus is consistently produced after MARC-145 cells are transfected with the RNA transcript produced from the PRRSV-CON cDNA clone. Moreover, the PRRSV-CON virus replicates as efficiently as our prototype PRRSV strain FL12, both in vitro and in vivo. Importantly, primary infection of pigs with PRRSV-CON virus confers significantly broader protection than the prototype PRRSV strain FL12 when tested upon subsequent challenge with a third unrelated heterologous PRRSV strain.

Collectively, our data demonstrate that the PRRSV-CON virus can serve as a potential vaccine candidate for the development of a novel PRRS vaccine with broader cross-protection.

H. Vu, F. Ma, W. Laegreid, A. Pattnaik, F. Osorio. Development of a synthetic porcine reproductive and respiratory syndrome virus strain that confers broader cross-protection. 2014 North American PRRS Symposium.

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list Swine News

Swine industry news in your email

Log in and sign up on the list

Related products in the shop

The shop specialized in the pig sector
Advice and technical service
More than 120 brands and manufacturers
You are not subscribed to this list Swine News

Swine industry news in your email

Log in and sign up on the list